Tucatinib “game changing” against stage IV HER2+ breast cancer, especially with brain metastases

Adding tucatinib to standard of care nearly tripled one-year progression-free survival

7-year study supports clinical trial of retinoic acid against stage IV melanoma

Melanoma deactivates the immune system. Study shows how to turn it back on.

Colorado study suggests new strategies against bone metastases from prostate cancer

Hope for targeted therapies and immunotherapy against bone mets

Do I Wait? Do I Not?

Cathy Noon (middle) and her supporters! After 8 years of serving as the Mayor of the city of Centennial, Cathy Noon was ready for a vacation. A shocking diagnosis of late-stage pancreatic cancer turned her plans of rest and relaxation upside down. Now, Cathy’s care...

New Colorado Center for Rare Melanomas leads research, treatment efforts

CU Cancer Center earns NCI designation as a Center for Rare Melanomas, along with $1.5M award

Latest News from the University of Colorado Cancer Center
Do I Wait? Do I Not?

Do I Wait? Do I Not?

Cathy Noon (middle) and her supporters! After 8 years of serving as the Mayor of the city of Centennial, Cathy Noon was ready for a vacation. A shocking diagnosis of late-stage pancreatic cancer turned her plans of rest and relaxation upside down. Now, Cathy’s care...

read more